Nabriva Therapeutics plc Quarterly Common Stock, Shares, Issued from Q4 2016 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Nabriva Therapeutics plc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2016 to Q2 2023.
  • Nabriva Therapeutics plc Common Stock, Shares, Issued for the quarter ending June 30, 2023 was 3.23M shares, a 95% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 3.23M -61.3M -95% Jun 30, 2023 10-Q 2023-10-19
Q1 2023 3.2M -58.5M -94.8% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 3.2M +933K +41.1% Dec 31, 2022 10-Q 2023-10-19
Q3 2022 3.02M -51.3M -94.4% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 64.6M +14.8M +29.8% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 61.7M +26.3M +74.3% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 2.27M -18.8M -89.2% Dec 31, 2021 10-K 2023-04-17
Q3 2021 54.3M -95.7M -63.8% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 49.7M -93.2M -65.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 35.4M -59.7M -62.8% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 21.1M +11.6M +123% Dec 31, 2020 10-K 2022-03-29
Q3 2020 150M +72M +92.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 143M +70.1M +96.1% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 95.1M +23.8M +33.3% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 9.45M -57.6M -85.9% Dec 31, 2019 10-K 2021-03-11
Q3 2019 78M +11.5M +17.3% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 72.9M +31.9M +78% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 71.3M +31.1M +77.3% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 67M +30.3M +82.6% Dec 31, 2018 10-K 2020-03-12
Q3 2018 66.5M Sep 30, 2018 10-Q 2018-11-06
Q2 2018 41M Jun 30, 2018 10-Q 2018-08-09
Q1 2018 40.2M Mar 31, 2018 10-Q 2018-05-08
Q4 2017 36.7M +34M +1250% Dec 31, 2017 10-K 2019-03-12
Q4 2016 2.72M Dec 31, 2016 10-K 2018-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.